Insider sale disclosed in SEC filing involving Bristol-Myers Squibb.

1 report, 1 independent Updated Sep 10

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Bristol-Myers Squibb SEC

Keep exploring

Part of

The FDA approved Zenbexus oral therapy for multiple myeloma, coinciding with disclosures regarding insider buying and selling transactions. All 1 developments

The entities involved

Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology (ESMO) Congress in Madrid.Sun 09:20
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.Sat 18:36
SEC
Slovak company
- CNBC reports on FED rate decisions and their impact on the Main Street economy and SEC yields.Sun 12:43
- SEC filing reported institutional investment activity for the Global X Uranium ETF.Sun 10:57

Related events

Insider purchase disclosed via SEC filing for Transcontinental Realty Investors, Inc. on August 6, 2026.Aug 7
State Street disclosed insider trades to the SEC on October 14, 2026.Oct 14
Insider buying disclosed via SEC filing by Kearny Financial.Jun 11
Sera Prognostics Inc. disclosed an insider stock transaction via a legal filing with the SEC on October 13, 2026.Oct 14
SoFi disclosed insider trades via an SEC filing on October 19, 2026.Oct 20

Coverage

Newest first; wire copies grouped

Sep 10dailypolitical.com